Crossmark

Fluorodeoxyglucose (FDG) PET/CT imaging analysis and clinical treatment evaluation in patients with SMARCA4-deficient tumors: case reports of four patients

Crossref DOI link: https://doi.org/10.1007/s00432-025-06207-9

Published Online: 2025-06-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Xueqin

Fu, Wei
Funding

Funding for this research was provided by:

Guangxi Zhuang Autonomous Region Health Department (Z-C20240890, Z-C20240890)
License Information

Text and Data Mining valid from 2025-06-03

Version of Record valid from 2025-06-03
More Information

Article History

Received: 5 March 2025

Accepted: 17 April 2025

First Online: 3 June 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below